إعلان
إعلان

EXAS

EXAS logo

Exact Sciences Corp

101.70
USD
برعاية
+0.14
+0.14%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

101.71

+0.01
+0.01%

تقارير أرباح EXAS

النسبة الإيجابية المفاجئة

EXAS تفوق 30 من 40 آخر التقديرات.

75%

التقرير التالي

بيانات التقرير القادم
١٧ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$878.11M
/
-$0.06
التغير الضمني من Q3 25 (Revenue/ EPS)
+3.22%
/
-40.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+23.08%
/
-98.72%

Exact Sciences Corp earnings per share and revenue

On ٠٣ نوفمبر ٢٠٢٥, EXAS reported earnings of -0.10 USD per share (EPS) for Q3 25, missing the estimate of -0.07 USD, resulting in a -40.06% surprise. Revenue reached 850.74 مليون, compared to an expected 826.38 مليون, with a 2.95% difference. The market reacted with a +3.90% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 25 المحللين forecast an EPS of -0.06 USD, with revenue projected to reach 878.11 مليون USD, implying an نقصان of -40.00% EPS, and زيادة of 3.22% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
logo
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
For Q3 2025, Exact Sciences Corp reported EPS of -$0.10, missing estimates by -40.06%, and revenue of $850.74M, 2.95% above expectations.
The stock price moved up 3.9%, changed from $66.98 before the earnings release to $69.59 the day after.
The next earning report is scheduled for ١٧ فبراير ٢٠٢٦.
Based on 25 المحللين, Exact Sciences Corp is expected to report EPS of -$0.06 and revenue of $878.11M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان